The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

Boryung announced on the 18th the launch of 'Ravetricks Capsule', a combination of aspirin and rabeprazole. Ravetricks is a ...

Ophthalmologists must take measures to avoid misdiagnosing age-related macular degeneration and consider mimics of the ...

TOKYO -- Japanese researchers from Keio University and elsewhere announced Thursday that they have begun a clinical trial on a gene therapy to restore light sensitivity in patients with retinitis ...

Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...

The following is a summary of “Associations between a healthy lifestyle score and retinal neurovascular health,” published in ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

In addition to rod photoreceptor loss, many mutations in rod photoreceptor-specific genes cause degeneration of other neuronal types. Identifying mechanisms of cell–cell interactions initiated ...

In view of the fact that RPE cell dysfunction/loss is believed to precede photoreceptor cell dysfunction/loss in STGD1 and that RPE cells can be generated in the laboratory relatively easily, a Phase ...

CARLSBAD, Calif.--(BUSINESS WIRE)--$LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...

Quantitative assessment of atrophic lesions determined by FAF, thickness of individual retinal layers and cone photoreceptor quantification was performed. Results BCVA ranged from 20/16 to 20/200.